megamillionsnumber|桂林三金：上海三金23年上半年净利润为负，主要因为整个生物医药行业遇冷，白帆生物订单落地情况不佳

Tonghuashun (300033) Financial Research Center, April 12megamillionsnumber, some investors asked Guilin Sanjin (002275)(002275), ask me about the company's semi-annual report, Shanghai Sanjin's revenue is more than 18 million yuan, and its net profit is 1megamillionsnumber.04.5 billion, why did this happen?megamillionsnumber？2 Compared with the 64 items disclosed in the 21st annual report, the company's effective invention patents are missing 2. Is this the reason for the expiration of the patents? thank

The company replied, Hello, Shanghai Sanjin's net profit for the first half of 2023 was negative, mainly due to the cold weather in the entire biomedicine industry and the poor implementation of orders from Baifan Biotech. Because the time for each patent application is different, some patents will expire, and the company will continue to apply for new patents. Thank you.

Tags:

Prev: gameshows|投资策略书的市场分析和风险评估：学习投资策略书中的市场分析和风险评估方法
Next: 30freespins| Trade growth forecast for 2024: China's stable market share leads global recovery, and trade volume is expected to increase by 2.6%